New Hope, PA, United States of America

Cailan Wang


 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2006-2020

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Cailan Wang: Innovator in Selective ROCK Inhibitors

Introduction

Cailan Wang is a prominent inventor based in New Hope, PA, known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Wang has focused on developing innovative compounds that serve as selective ROCK inhibitors. His work has the potential to impact various medical conditions, including cardiovascular and inflammatory disorders.

Latest Patents

Wang's latest patents include groundbreaking inventions such as "Lactam, cyclic urea and carbamate, and triazolone derivatives as potent and selective rock inhibitors." This invention provides compounds of Formula (I) or their stereoisomers, tautomers, or pharmaceutically acceptable salts. These compounds are designed to selectively inhibit ROCK, offering new avenues for treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and inflammatory disorders. Another notable patent is "Tricyclic pyrido-carboxamide derivatives as rock inhibitors," which similarly presents compounds of Formula (I) with the same therapeutic applications.

Career Highlights

Cailan Wang is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in pharmacology. His work at this leading pharmaceutical company allows him to collaborate with other experts in the field and contribute to the development of innovative treatments.

Collaborations

Wang has worked alongside talented colleagues, including Mimi Lifen Quan and Zilun Hu. Their collaborative efforts have further enhanced the research and development of selective ROCK inhibitors.

Conclusion

Cailan Wang's innovative work in the field of selective ROCK inhibitors showcases his dedication to advancing medical science. His patents reflect a commitment to addressing critical health issues through pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…